References
- Richter M. Generalized reticular cell sarcoma of lymph nodes associated with lymphatic leukemia. Am J Pathol 1928;6:285–299.
- Lortholary P, Ripault M, Boiron M. [Richter's syndrome]. Nouv Rev Fr Hematol 1964;72:456–457.
- Armitage JO, Dick FR, Corder MP. Diffuse histiocytic lymphoma complicating chronic lymphocytic leukemia. Cancer 1978;41:422–427.
- Foucar K, Rydell RE. Richter's syndrome in chronic lymphocytic leukemia. Cancer 1980;46:11C8–134.
- Robertson LE, Pugh W, O’Brien S, . Richter's syndrome: a report on 39 patients. J Clin Oncol 1993;11:1985–1989.
- Rai KR, Peterson BL, Appelbaum FR, . Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N Engl J Med 2000;343:1750–1757.
- Wiernik PH. Second neoplasms in patients with chronic lymphocytic leukemia. Curr Treat Options Oncol 2004;5:215–223.
- Tsimberidou AM, Wen W, McLaughlin P, . Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009;27:904–910.
- Morrison VA, Rai KR, Peterson BL, . Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011. J Clin Oncol 2002;20:3878–3884.
- Rai K, Peterson BL, Appelbaum FR, . Long-term survival analysis of the North American intergroup study C9011 comparing fludarabine (F) and chlorambucil © in previously untreated patients with chronic lymphocytic leukemia (CLL). Blood 2009;114(Suppl. 1): Abstract 536.
- Jelic S, Jovanovic V, Milanovic N, . Richter syndrome with emphasis on large-cell non-Hodgkin lymphoma in previously unrecognized subclinical chronic lymphocytic leukemia. Neoplasia 1997;44:63–68.
- Mauro FR, Foa R, Giannarelli D, . Clinical characteristics and outcome of young chronic lymphocytic leukemia patients: a single institution study of 204 cases. Blood 1999;94:448–454.
- Rossi D, Cerri M, Capello D, . Biological and clinical risk factors of chronic lymphocytic leukaemia transformation to Richter syndrome. Br J Haematol 2008;142:202–215.
- Keating MJ, O’Brien S, Lerner S, . Long-term follow-up of patients with chronic lymphocytic leukemia (CLL) receiving fludarabine regimens as initial therapy. Blood 1998;92:1165–1171.
- Thornton PD, Bellas C, Santon A, . Richter's transformation of chronic lymphocytic leukemia: the possible role of fludarabine and the Epstein-Barr virus in its pathogenesis. Leuk Res 2005;29:389–395.
- Deambrogi C, Cresta S, Cerri M, . 14q32 translocations and risk of Richter transformation in chronic lymphocytic leukaemia. Br J Haematol 2008;144:131–133.
- Aydin S, Rossi D, Bergui L, . CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome? Blood 2008;111:5646–5653.
- Rossi D, Spina V, Cerri M, . Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. Clin Cancer Res 2009;15:4415–4422.
- Maddocks-Christianson K, Slager SL, Zent CS, . Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukemia. Br J Haematol 2007;139:398–404.
- Leleu X, Soumerai J, Rocarro A, . Increased incidence of transformation and myelodysplasis/acute leukemia in patients with Waldenstrom macroglobulinemia treated with nucleoside analogs. J Clin Oncol 2008;27:250–255.
- Robak T. Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukemia. Hematology 2004;9:387–400.
- Robak T, Blonski JZ, Gora-Tybor J, . Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer 2004;40:383–389.